Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner.

Poole E, Walther A, Raven K, Benedict CA, Mason GM, Sinclair J.

J Virol. 2013 Apr;87(8):4261-71. doi: 10.1128/JVI.03497-12. Epub 2013 Jan 30.

2.

HCMV protein LUNA is required for viral reactivation from latently infected primary CD14⁺ cells.

Keyes LR, Hargett D, Soland M, Bego MG, Rossetto CC, Almeida-Porada G, St Jeor S.

PLoS One. 2012;7(12):e52827. doi: 10.1371/journal.pone.0052827. Epub 2012 Dec 26.

3.

Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

Goodrum FD, Jordan CT, High K, Shenk T.

Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16255-60. Epub 2002 Nov 27.

4.

Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Kim JH, Collins-McMillen D, Buehler JC, Goodrum FD, Yurochko AD.

J Virol. 2017 Feb 14;91(5). pii: e01206-16. doi: 10.1128/JVI.01206-16. Print 2017 Mar 1.

5.

Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D.

J Virol. 2014 Aug;88(16):9391-405. doi: 10.1128/JVI.00934-14. Epub 2014 Jun 11.

6.

Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.

Huang MM, Kew VG, Jestice K, Wills MR, Reeves MB.

J Virol. 2012 Aug;86(16):8507-15. doi: 10.1128/JVI.00598-12. Epub 2012 May 30.

7.

Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency.

Qin Q, Penkert RR, Kalejta RF.

J Virol. 2013 Sep;87(17):9886-94. doi: 10.1128/JVI.01726-13. Epub 2013 Jul 3.

8.

Sleepless latency of human cytomegalovirus.

Poole E, Sinclair J.

Med Microbiol Immunol. 2015 Jun;204(3):421-9. doi: 10.1007/s00430-015-0401-6. Epub 2015 Mar 14. Review.

9.

Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.

Rossetto CC, Tarrant-Elorza M, Pari GS.

PLoS Pathog. 2013;9(5):e1003366. doi: 10.1371/journal.ppat.1003366. Epub 2013 May 23.

10.

Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection.

Weekes MP, Tan SY, Poole E, Talbot S, Antrobus R, Smith DL, Montag C, Gygi SP, Sinclair JH, Lehner PJ.

Science. 2013 Apr 12;340(6129):199-202. doi: 10.1126/science.1235047.

11.
12.

Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency.

Zhuravskaya T, Maciejewski JP, Netski DM, Bruening E, Mackintosh FR, St Jeor S.

Blood. 1997 Sep 15;90(6):2482-91.

13.

Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations.

Albright ER, Kalejta RF.

J Virol. 2013 Sep;87(17):9802-12. doi: 10.1128/JVI.01436-13. Epub 2013 Jul 3.

14.

Human cytomegalovirus manipulation of latently infected cells.

Sinclair JH, Reeves MB.

Viruses. 2013 Nov 21;5(11):2803-24. doi: 10.3390/v5112803. Review.

15.

Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.

Humby MS, O'Connor CM.

J Virol. 2015 Dec 30;90(6):2959-70. doi: 10.1128/JVI.02507-15.

16.

Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells.

Mason GM, Jackson S, Okecha G, Poole E, Sissons JG, Sinclair J, Wills MR.

PLoS Pathog. 2013;9(10):e1003635. doi: 10.1371/journal.ppat.1003635. Epub 2013 Oct 10.

17.

Aspects of human cytomegalovirus latency and reactivation.

Reeves M, Sinclair J.

Curr Top Microbiol Immunol. 2008;325:297-313. Review.

PMID:
18637513
18.

[Latency and reactivation of HCMV].

Eizuru Y.

Nihon Rinsho. 2006 Mar;64 Suppl 3:435-9. Review. Japanese. No abstract available.

PMID:
16615510
19.

Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency.

Cheng S, Caviness K, Buehler J, Smithey M, Nikolich-Žugich J, Goodrum F.

Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):E10586-E10595. doi: 10.1073/pnas.1710522114. Epub 2017 Nov 20.

20.

Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.

Poole E, Groves I, MacDonald A, Pang Y, Alcami A, Sinclair J.

J Virol. 2009 Apr;83(8):3581-90. doi: 10.1128/JVI.02072-08. Epub 2009 Jan 28.

Supplemental Content

Support Center